Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NBSE | Common Stock, Par Value $0.0001 per Share | Sale | -$186K | -129K | -45.71% | $1.44 | 153K | Sep 14, 2023 | Direct | |
transaction | NBSE | Common Stock, Par Value $0.0001 per Share | Sale | -$130K | -103K | -67.39% | $1.26 | 50K | Sep 15, 2023 | Direct | |
transaction | NBSE | Common Stock, Par Value $0.0001 per Share | Sale | -$59.5K | -50K | -100% | $1.19 | 0 | Sep 18, 2023 | Direct |
As of September 18, 2023, Symetryx Corporation does not own any shares of Common Stock of NeuBase Therapeutics, Inc.